These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6140924)

  • 1. Interactions of kinins with angiotensin I converting enzyme (kininase II).
    Odya CE; Wilgis FP; Vavrek RJ; Stewart JM
    Biochem Pharmacol; 1983 Dec; 32(24):3839-47. PubMed ID: 6140924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of angiotensin I converting enzyme: effects of kinins, bacitracin, gamma-aminobutyric and epsilon-aminocaproic acids, and related compounds on substrate binding and catalysis in vitro.
    Odya CE; Wilgis FP
    Can J Physiol Pharmacol; 1986 Jan; 64(1):50-4. PubMed ID: 3006897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies of myometrial bradykinin receptor-like binding.
    Fredrick MJ; Vavrek RJ; Stewart JM; Odya CE
    Biochem Pharmacol; 1984 Sep; 33(18):2887-92. PubMed ID: 6148089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kininases and vascular responses to kinins.
    Babiuk C; Marceau F; St-Pierre S; Regoli D
    Eur J Pharmacol; 1982 Feb; 78(2):167-74. PubMed ID: 6122586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery.
    Gorelik G; Carbini LA; Scicli AG
    J Pharmacol Exp Ther; 1998 Jul; 286(1):403-10. PubMed ID: 9655885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin I converting enzyme and kinin-hydrolyzing enzymes along the rabbit nephron.
    Marchetti J; Roseau S; Alhenc-Gelas F
    Kidney Int; 1987 Mar; 31(3):744-51. PubMed ID: 3033387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation.
    Dendorfer A; Reibetamann S; Wolfrum S; Raasch W; Dominiak P
    Hypertension; 2001 Jul; 38(1):142-6. PubMed ID: 11463775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of kinins on angiotensin I conversion in the local circulation.
    Sasaguri M; Ideishi M; Ikeda M; Arakawa K
    Clin Exp Hypertens A; 1990; 12(4):551-69. PubMed ID: 2196127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B2 bradykinin receptor-like binding in rat renomedullary interstitial cells.
    Fredrick MJ; Abel FC; Rightsel WA; Muirhead EE; Odya CE
    Life Sci; 1985 Jul; 37(4):331-8. PubMed ID: 2861552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
    Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
    Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue.
    Gera L; Roy C; Bawolak MT; Bouthillier J; Adam A; Marceau F
    Pharmacol Res; 2011 Nov; 64(5):528-34. PubMed ID: 21864683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production.
    Galizzi JP; Bodinier MC; Chapelain B; Ly SM; Coussy L; Giraud S; Neliat G; Jean T
    Br J Pharmacol; 1994 Oct; 113(2):389-94. PubMed ID: 7834189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.
    Cyr M; Lepage Y; Blais C; Gervais N; Cugno M; Rouleau JL; Adam A
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H275-83. PubMed ID: 11406494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
    Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
    Carmona AK; Juliano L
    Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats.
    Sun Y; Ratajska A; Weber KT
    J Mol Cell Cardiol; 1995 Feb; 27(2):813-22. PubMed ID: 7776388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.